GLP-1s for alcohol use disorder

Psychiatric Times summarised a presentation at the American Psychiatric Association meeting this week: Joji Suzuki MD’s research and psychiatric implications for glucagon-like peptide-1 (GLP-1) receptor agonists to help treat substance use disorders. See also the Recovery Research Institute on Can GLP-1 medications prevent addiction and reduce its harms?